VOID AFTER 5:00 P.M., EASTERN TIME,
ON SEPTEMBER 30, 2010
THIS WARRANT AND THE SHARES OF COMMON STOCK UNDERLYING THIS WARRANT
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
"SECURITIES ACT"), AND MAY NOT BE SOLD, PLEDGED, ASSIGNED OR OTHERWISE
TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION UNDER THE
SECURITIES ACT OR IN A TRANSACTION THAT, IN THE OPINION OF COUNSEL TO JAVELIN
PHARMACEUTICALS, INC., QUALIFIES AS AN EXEMPT TRANSACTION UNDER THE
SECURITIES ACT AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER.
No. 2005 CS-92 25,000 Shares
JAVELIN PHARMACEUTICALS, INC.
COMMON STOCK PURCHASE WARRANT AGREEMENT
JAVELIN PHARMACEUTICALS, INC., a Delaware corporation (the "Company"), hereby grants to THE
INVESTOR RELATIONS GROUP INC., (the "Initial Holder"), subject to the terms set forth in this Common
Stock Purchase Warrant Agreement (the "Warrant Agreement"), the right to exercise Common Stock Purchase
Warrants (the "Warrants") for the purchase from the Company of up to 25,000 shares (the "Shares") of the
Company's Common Stock, at an exercise price of $3.00 per share, subject to adjustment from time to time
pursuant to Section 3 hereof (the "Exercise Price"). The term "Common Stock" means, unless the context
otherwise requires, the Company's Common Stock, par value $.001 per share, or other securities or property at
the time deliverable upon the exercise of this Warrant.
This Warrant is issued to the Initial Holder in consideration of the March 22, 2005 letter agreement between the
Initial Holder and Intrac, Inc. Effective September 7, 2005, Intrac merged with and into the Company, and the
Company assumed all outstanding warrants to purchase Intrac common stock on the same terms as the Intrac
warrants, except exercisable for shares of the Company's Common Stock.
Timing of Exercise. The Warrants shall be exercisable at any time in whole or in part from time to time
commencing as of the date hereof and expiring at 5:00 P.